Latest News for: hydrus

Edit

Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent ...

Nasdaq Globe Newswire 29 Apr 2024
(Nasdaq ... Sight Sciences asserted that Alcon’s and Ivantis’ sale of the Hydrus® Microstent infringed three key patents. .
Edit

The Hydrus Underwater Drone Wants to Be the DJI of the Sea

PetaPixel 14 Mar 2024
... (or seascape) with its new Hydrus autonomous underwater vehicle (AUV).
Edit

Hydrus

Ravalli Republic 14 Jan 2024
Hi, I'm Hydrus! I'm as ...
Edit

🌟Fomalhaut in the constellation Piscis Austrinus & 🌟Head Of Hydrus

Bitchute 06 Feb 2023
Go to the source via the article link to view the video ....
Edit

Hydrus rollercoaster and casino pier reveiw(seaside heights,nj)

Bitchute 02 Feb 2023
Go to the source via the article link to view the video ....
Edit

Hydrus Helps Companies Improve ESG Performance (MongoDB Inc)

Public Technologies 18 Jan 2023
San Francisco-based startup, Hydrus, is helping companies make ESG data more usable and actionable ... Hydrus offers users a first-rate UI/UX so that even non-technical users can leverage the platform.
Edit

Advanced Navigation announces Hydrus autonomous underwater drone

ZDNet 01 Apr 2022
Touted to help scientists and researchers collect more data about the ocean ... .
Edit

Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio

Business Wire 10 Jan 2022
GENEVA--(BUSINESS WIRE)--Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio ... .
Edit

Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio (Alcon AG)

Public Technologies 10 Jan 2022
It also allows Alcon to begin its future growth plans to bring Hydrus Microstent to more international markets and prioritize its ongoing evidence-based research ... About Hydrus Microstent ... the Hydrus ...
Edit

Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma

PR Newswire 15 Dec 2021
Up to 80% of glaucoma patients have mild to moderate disease severity, and a standalone Hydrus Microstent procedure could provide an important new treatment option in the U.S ... Ivantis, Hydrus, and Tri-Modal are registered trademarks of Ivantis Inc.
Edit

Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone ...

Longview News-Journal 15 Dec 2021
Up to 80% of glaucoma patients have mild to moderate disease severity, and a standalone Hydrus Microstent procedure could provide an important new treatment option in the U.S ... About the Hydrus Microstent.
  • 1

Article Search

tools

Most Viewed

×
×
×
×